US drug approvals
120 approvals with a product on the US market
- Hydrocodone Bitartrate And Homatropine Methylbromide ANDA220509 · approved 22 Sep 2026
- Everolimus ANDA219464 · approved 30 Jun 2026
- Atomoxetine Hydrochloride ANDA218875 · approved 16 Jun 2026
- Paliperidone ANDA205402 · approved 7 May 2026
- Nitrofurantoin (Monohydrate/Macrocrystals) ANDA220269 · approved 7 Apr 2026
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.